- Research works
- 65 ▲ 60% vs 2013–17
- Citations
- 1.8k 27.6 per fractional work
- Top-10% rate
- 4.0% record average 16.5%
- Open access
- 61% world 28%
Not ranked overall: Ligand Pharmaceuticals (United Kingdom) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Neuroscience, 4.6×. Every wedge is a field page.
- Neuroscience 4.6×
- Economics, Econometrics and Finance 4.1×
- Immunology and Microbiology 2.9×
- Biochemistry, Genetics and Molecular Biology 2.2×
- Dentistry 1.8×
- Medicine 1.8×
- Veterinary 1.6×
- Computer Science 1.3×
- Nursing 1.2×
- Environmental Science 0.8×
- Business, Management and Accounting 0.7×
- Psychology 0.7×
- Agricultural and Biological Sciences 0.7×
- Engineering 0.4×
- Arts and Humanities 0.3×
- Social Sciences 0.2×
- Chemistry 0.2×
- Materials Science 0.2×
- Health Professions 0.2×
Who are the top researchers at Ligand Pharmaceuticals (United Kingdom)?
Ranked on the composite score, Alison Prowle lead among researchers whose main affiliation is Ligand Pharmaceuticals (United Kingdom).
- 1 Alison Prowle United Kingdom · #1,529,148 worldwide 2 citations · 23 works
Which keywords describe research at Ligand Pharmaceuticals (United Kingdom)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer, Angiogenesis, Inflammation, Epidemiology, Glycosylation, Immune System, Innovation and Glycans.
- Trypanosoma cruzi
- Geopolymer
- Vector Control
- Pharmacokinetics
- Heterocyclic Compounds
- Oligosaccharide Synthesis
- Drug Resistance
- Global Collaboration
- Financial Security
- Depression
- Medicinal Chemistry
- Intellectual Property
- Proteoglycans
- Sustainable Development
- Cell Signaling
- Glycans
- Immune System
- Oxidative Stress
- Angiogenesis
- Inflammation
- Epidemiology
- Cancer
- Innovation
- Glycosylation
- Machine Learning
- Mucins
- Synaptic Plasticity
- Hyaluronan
- Toll-like Receptors
- Cancer Therapy
- Metabolism
- Chemotherapy
- Genome Sequence
- Health Biotechnology
- Glycosidase Inhibitors
- Data Analysis
- Normalization
- Vaccine Development
- Chagas Disease
- Model-Based Development
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology5▲ 2.0×22 topics
- Inflammation5▲ 3.4×23 topics
- Cancer5▲ 5.2×13 topics
- Angiogenesis4▲ 13×6 topics
- Innovation3▲ 4.8×5 topics
- Oxidative Stress3▲ 2.3×14 topics
- Glycosylation3▲ 18×2 topics
- Immune System2▲ 12×4 topics
- Machine Learning2▲ 1.63×7 topics
- Glycans2▲ 41×1 topic
- Mucins2▲ 41×1 topic
- Cell Signaling2▲ 9.4×3 topics
- Synaptic Plasticity2▲ 10×3 topics
- Sustainable Development2▲ 2.5×5 topics
- Hyaluronan2▲ 102×1 topic
- Proteoglycans2▲ 102×1 topic
- Toll-like Receptors2▲ 17×3 topics
- Intellectual Property2▲ 25×2 topics
- Cancer Therapy2▲ 3.8×10 topics
- Medicinal Chemistry2▲ 6.5×3 topics
- Metabolism2▲ 3.5×6 topics
- Depression1▲ 2.9×7 topics
- Chemotherapy1▲ 2.9×7 topics
- Financial Security1▲ 37×2 topics
- Genome Sequence1▲ 18×2 topics
- Global Collaboration1▲ 50×1 topic
- Health Biotechnology1▲ 108×1 topic
- Drug Resistance1▲ 5.8×2 topics
- Glycosidase Inhibitors1▲ 36×1 topic
- Oligosaccharide Synthesis1▲ 36×1 topic
- Data Analysis1▲ 5.3×3 topics
- Heterocyclic Compounds1▲ 11×3 topics
- Normalization1▲ 23×2 topics
- Pharmacokinetics1▲ 6.0×3 topics
- Vaccine Development1▲ 5.3×4 topics
- Vector Control1▲ 14×2 topics
- Chagas Disease1▲ 57×1 topic
- Geopolymer1▲ 19×2 topics
- Model-Based Development1▲ 40×2 topics
- Trypanosoma cruzi1▲ 57×1 topic
Which research topics does Ligand Pharmaceuticals (United Kingdom) publish most on?
By volume in 2022–2025: Biotechnology and Related Fields, Tryptophan and brain disorders, Digital Transformation in Financial Services and Labor Market and Education.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Biotechnology and Related Fields Public Health, Environmental and Occupational Health 1 works
- 2 Tryptophan and brain disorders Biological Psychiatry 1 works
- 3 Digital Transformation in Financial Services General Economics, Econometrics and Finance 1 works
- 4 Labor Market and Education Economics and Econometrics 1 works
- 5 Business and Economic Development Management, Monitoring, Policy and Law 1 works
- 6 Autism Spectrum Disorder Research Cognitive Neuroscience 0 works
- 7 Wound Healing and Treatments Rehabilitation 0 works
- 8 Speech and dialogue systems Artificial Intelligence 0 works
- 9 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
- 10 Software Engineering and Design Patterns Development 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Ligand Pharmaceuticals (United Kingdom)'s research output changed?
Output in 2018–2022 was 60% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in London
- University College London
- Imperial College London
- King's College London
- Queen Mary University of London
- London School of Economics and Political Science
- University of London
- Brunel University of London
- London School of Hygiene & Tropical Medicine
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.